Celcuity Appoints Polly Murphy, D.V.M., Ph.D., to Board of Directors
Seasoned executive brings over two decades of pharmaceutical business development and commercial strategy experience to Celcuity's Board of DirectorsMINNEAPOLIS, MN / ACCESSWIRE / September 14, 2022 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage …
Weiterlesen »